Filament Health Corp.

Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the associated IP to Psyence for use in its upcoming clinical trials. Thanks to this license,...

Cybin Debuts On The NYSE Last week, Cybin (NYSE: CYBN) began listing its stock on the New York Stock Exchange. The company is the first in the sector to enter the NYSE, following a trend of five psychedelics companies to debut on the Nasdaq since the beginning of the year. “This validation by...